Capital Research Global Investors Medtronic PLC Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Medtronic PLC stock. As of the latest transaction made, Capital Research Global Investors holds 30,884,412 shares of MDT stock, worth $2.51 Billion. This represents 0.63% of its overall portfolio holdings.

Number of Shares

30,884,412

Previous 28,840,303 7.09%

Holding current value

$2.51 Billion

Previous $2.38 Billion 13.29%

% of portfolio

0.63%

Previous 0.6%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$82.84 - $88.09 $169 Million - $180 Million	2,044,109 Added 7.09%	30,884,412 $2.69 Billion
Q4 2023 Feb 13, 2024	SELL	$69.43 - $83.43 $228 Million - $274 Million	-3,288,638 Reduced 10.24%	28,840,303 $2.38 Billion
Q3 2023 Nov 13, 2023	BUY	$78.22 - $90.4 $49.7 Million - $57.4 Million	635,170 Added 2.02%	32,128,941 $2.52 Billion
Q2 2023 Aug 11, 2023	BUY	$79.47 - $91.38 $117 Million - $135 Million	1,475,241 Added 4.91%	31,493,771 $2.77 Billion
Q1 2023 May 15, 2023	BUY	$76.72 - $87.58 $92.4 Million - $105 Million	1,203,861 Added 4.18%	30,018,530 $2.42 Billion

Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $2.83 Million - $3.26 Million	37,199 Added 0.13%	28,814,669 $2.24 Billion
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $221 Million - $261 Million	2,742,283 Added 10.53%	28,777,470 $2.32 Billion
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $351 Million - $454 Million	4,011,590 Added 18.21%	26,035,187 $2.34 Billion
Q1 2022 May 16, 2022	BUY	$100.58 - $112.38 $141 Million - $158 Million	1,405,249 Added 6.82%	22,023,597 $2.44 Billion
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $197 Million - $252 Million	1,974,556 Added 10.59%	20,618,348 $2.13 Billion
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $12.9 Million - $14.2 Million	105,057 Added 0.57%	18,643,792 $2.34 Billion
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $394 Million - $439 Million	3,337,462 Added 21.96%	18,538,735 $2.3 Billion
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $602 Million - $649 Million	5,419,122 Added 55.4%	15,201,273 $1.8 Billion
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $257 Million - $300 Million	2,559,030 Added 35.43%	9,782,151 $1.15 Billion
Q3 2020 Nov 13, 2020	BUY	$90.13 - $108.78 $8.25 Million - $9.96 Million	91,576 Added 1.28%	7,223,121 $751 Million
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $31.7 Million - $39 Million	377,038 Added 5.58%	7,131,545 $654 Million
Q1 2020 May 15, 2020	BUY	$72.92 - $121.3 $49.1 Million - $81.7 Million	673,266 Added 11.07%	6,754,507 $609 Million
Q4 2019 Feb 18, 2020	BUY	$104.49 - $114.54 $77.7 Million - $85.2 Million	743,510 Added 13.93%	6,081,241 $690 Million
Q3 2019 Nov 14, 2019	BUY	$98.02 - $111.18 $95.9 Million - $109 Million	978,189 Added 22.44%	5,337,731 $580 Million
Q2 2019 Aug 14, 2019	SELL	$84.15 - $99.38 $176 Million - $208 Million	-2,092,842 Reduced 32.44%	4,359,542 $425 Million
Q1 2019 May 15, 2019	SELL	$82.45 - $93.79 $18.2 Million - $20.7 Million	-220,784 Reduced 3.31%	6,452,384 $588 Million
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $49,506 - $57,405	577 Added 0.01%	6,673,168 $607 Million
Q3 2018 Nov 14, 2018	SELL	$85.91 - $99.17 $579 Million - $668 Million	-6,739,153 Reduced 50.25%	6,672,591 $656 Million
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $267 Million - $303 Million	-3,447,949 Reduced 20.45%	13,411,744 $1.15 Billion
Q1 2018 May 15, 2018	SELL	$76.55 - $87.26 $651 Million - $742 Million	-8,501,104 Reduced 33.52%	16,859,693 $1.35 Billion
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $307 Million - $333 Million	-3,990,443 Reduced 13.6%	25,360,797 $2.05 Billion
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $2.28 Billion - $2.48 Billion	29,351,240	29,351,240 $2.28 Billion

Others Institutions Holding MDT

# of Institutions

2,230

Shares Held

1.05B

Call Options Held

6.1M

Put Options Held

7.84M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Medtronic PLC Transaction History